Literature DB >> 18432952

Differentiation and characterization of myeloid cells.

Peter Gaines1, Nancy Berliner.   

Abstract

Recent molecular studies of myeloid differentiation have utilized several in vitro models of myelopoiesis. Hematopoietic progenitors expressing the CD34+ antigen can be induced in vitro in a process that recapitulates the normal myeloid development. Two human leukemic cell lines, NB-4 and HL-60, have been demonstrated to undergo retinoic acid-induced myeloid development, however, both cell lines exhibit defects in the upregulation of late-expressed neutrophil-specific genes. In contrast, two murine factor-dependent cell models of myelopoiesis express the full range of neutrophil maturation markers: 32Dcl3 cells, which undergo G-CSF-induced myeloid maturation, and EML/EPRO cells, which develop into mature neutrophils in response to cytokines and retinoic acid. In this unit, the induction of myeloid maturation in each of these model systems is described. Commonly used techniques to test for myeloid characteristics of developing cells are also described. Together, these assays provide a solid foundation for in vitro investigations of myeloid development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18432952     DOI: 10.1002/0471142735.im22f05s67

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  8 in total

1.  A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy.

Authors:  Roy L Kao; Laurel C Truscott; Tzu-Ting Chiou; Wenting Tsai; Anna M Wu; Satiro N De Oliveira
Journal:  Hum Gene Ther       Date:  2019-04       Impact factor: 5.695

2.  The human granulocyte nucleus: Unusual nuclear envelope and heterochromatin composition.

Authors:  Ada L Olins; Monika Zwerger; Harald Herrmann; Hanswalter Zentgraf; Amos J Simon; Marc Monestier; Donald E Olins
Journal:  Eur J Cell Biol       Date:  2008-04-08       Impact factor: 4.492

3.  Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.

Authors:  Satiro Nakamura De Oliveira; Christine Ryan; Francesca Giannoni; Cinnamon L Hardee; Irena Tremcinska; Behrod Katebian; Jennifer Wherley; Arineh Sahaghian; Andy Tu; Tristan Grogan; David Elashoff; Laurence J N Cooper; Roger P Hollis; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2013-10       Impact factor: 5.695

4.  Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells.

Authors:  Lucas M Sjeklocha; Chang-Won Park; Phillip Y-P Wong; Mark J Roney; John D Belcher; Dan S Kaufman; Gregory M Vercellotti; Robert P Hebbel; Clifford J Steer
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

5.  Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies.

Authors:  Chih Long Liu; Stephanie Tangsombatvisit; Jacob M Rosenberg; Gil Mandelbaum; Emily C Gillespie; Or P Gozani; Ash A Alizadeh; Paul J Utz
Journal:  Arthritis Res Ther       Date:  2012-02-02       Impact factor: 5.156

6.  Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo.

Authors:  Andreas Glenthøj; Katrin Nickles; Jack Cowland; Niels Borregaard
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

7.  IL-3 and oncogenic Abl regulate the myeloblast transcriptome by altering mRNA stability.

Authors:  Jason Ernst; Louis Ghanem; Ziv Bar-Joseph; Michael McNamara; Jason Brown; Richard A Steinman
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

8.  Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment.

Authors:  Oriana Romano; Clelia Peano; Guidantonio Malagoli Tagliazucchi; Luca Petiti; Valentina Poletti; Fabienne Cocchiarella; Ermanno Rizzi; Marco Severgnini; Alessia Cavazza; Claudia Rossi; Pasqualepaolo Pagliaro; Alessandro Ambrosi; Giuliana Ferrari; Silvio Bicciato; Gianluca De Bellis; Fulvio Mavilio; Annarita Miccio
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.